 Ergolines
"Ergolines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A series of structurally-related alkaloids that contain the ergoline backbone structure.
| Descriptor ID |
D004873
|
| MeSH Number(s) |
D03.132.327.287 D03.549.439
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Ergolines".
Below are MeSH descriptors whose meaning is more specific than "Ergolines".
This graph shows the total number of publications written about "Ergolines" by people in this website by year, and whether "Ergolines" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1982 | 1 | 0 | 1 | | 1983 | 2 | 0 | 2 | | 1985 | 2 | 0 | 2 | | 1998 | 0 | 1 | 1 | | 1999 | 0 | 1 | 1 | | 2005 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Ergolines" by people in Profiles.
-
Goetz CG, Poewe W, Rascol O, Sampaio C. Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Mov Disord. 2005 May; 20(5):523-39.
-
Widnell KL, Comella C. Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations. Mov Disord. 2005; 20 Suppl 11:S30-7.
-
Pappert EJ, Goetz CG, Vu TQ, Ling ZD, Leurgans S, Raman R, Carvey PM. Animal model of posthypoxic myoclonus: effects of serotonergic antagonists. Neurology. 1999 Jan 01; 52(1):16-21.
-
Pappert EJ, Goetz CG, Stebbins GT, Belden M, Carvey PM. 5-Hydroxytryptophan-induced myoclonus in guinea pigs: mediation through 5-HT1/2 receptor subtypes. Eur J Pharmacol. 1998 Apr 17; 347(1):51-6.
-
Tanner CM, Chhablani R, Goetz CG, Klawans HL. Pergolide mesylate: lack of cardiac toxicity in patients with cardiac disease. Neurology. 1985 Jun; 35(6):918-21.
-
Goetz CG, Tanner CM, Glantz RH, Klawans HL. Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide. Neurology. 1985 May; 35(5):749-51.
-
Goetz CG, Tanner CM, Glantz R, Klawans HL. Pergolide in Parkinson's disease. Arch Neurol. 1983 Dec; 40(13):785-7.
-
Klawans HL, Tanner CM, Glatt S, Goetz CG. A 6-month trial of pergolide mesylate in the treatment of idiopathic Parkinson's disease. Adv Neurol. 1983; 37:75-83.
-
Tanner CM, Goetz CG, Glantz RH, Glatt SL, Klawans HL. Pergolide mesylate and idiopathic Parkinson disease. Neurology. 1982 Oct; 32(10):1175-9.
-
Weiner WJ, Carvey PM, Nausieda PA, Klawans HL. Dopaminergic antagonism of L-5-hydroxytryptophan-induced myoclonic jumping behavior. Neurology. 1979 Dec; 29(12):1622-5.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|